Acute Interstitial Nephritis in a Patient With Non-Small Cell Lung Cancer Under Immunotherapy With Nivolumab

Case Reports in Nephrology
doi 10.1155/2019/3614980
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Nivolumab-Induced Severe Acute Kidney Injury With a Long Latent Phase in a Patient With Non-Small-Cell Lung Cancer: A Case Report

Clinical Case Reports
Medicine
2018English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient

Case Reports in Oncological Medicine
Oncology
2017English

Tuberculosis Infection in a Patient Treated With Nivolumab for Non-Small Cell Lung Cancer: Case Report and Literature Review

Frontiers in Oncology
Cancer ResearchOncology
2019English

FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient With Small-Cell Lung Cancer

Case Reports in Neurological Medicine
2019English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

Immunotherapy for Non-Small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome: Erratum

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy